Explore more publications!
Puerto Rico Technology Today
Got News to Share?

Puerto Rico Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 5, 2026

ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directors
January 5, 2026

ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directors

Indeterminate GlobeNewswire
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates
January 5, 2026

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

Indeterminate GlobeNewswire
BridgeBio to Participate in the J.P. Morgan Healthcare Conference
January 5, 2026

BridgeBio to Participate in the J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Angitia Biopharmaceuticals Completes Enrollment of Phase 2 ARTEMIS Trial Evaluating AGA2118 for the Treatment of Osteoporosis
January 5, 2026

Angitia Biopharmaceuticals Completes Enrollment of Phase 2 ARTEMIS Trial Evaluating AGA2118 for the Treatment of Osteoporosis

Indeterminate GlobeNewswire
3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position
January 5, 2026

3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position

Indeterminate GlobeNewswire
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
January 5, 2026

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Indeterminate GlobeNewswire
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH
January 5, 2026

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH

Indeterminate GlobeNewswire
Allot to Present at the Needham Growth Conference on January 14, 2026
January 5, 2026

Allot to Present at the Needham Growth Conference on January 14, 2026

Indeterminate GlobeNewswire
Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)
January 5, 2026

Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Indeterminate GlobeNewswire
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 5, 2026

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Indeterminate GlobeNewswire
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026

Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines
January 5, 2026

Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions